Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
| Status: | Recruiting |
|---|---|
| Conditions: | Vaccines, Brain Cancer |
| Therapuetic Areas: | Immunology / Infectious Diseases, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/9/2018 |
| Start Date: | July 2011 |
| End Date: | January 2020 |
| Contact: | Jona C Bernabe |
| Email: | Calitij@sutterhealth.org |
| Phone: | 415-600-1151 |
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and
malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome
is curative endoscopic resection. Secondary outcomes include resection technique utilized,
rates of en bloc resection and adverse event rates, including infection, bleeding,
perforation and death, and one-year survival rates.
malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome
is curative endoscopic resection. Secondary outcomes include resection technique utilized,
rates of en bloc resection and adverse event rates, including infection, bleeding,
perforation and death, and one-year survival rates.
Inclusion Criteria:
- Patients age >18 years that have been referred for endoscopic treatment of GI lesions.
Exclusion Criteria:
- Patients who do not sign informed consent
- Patients for whom endoscopic treatment was not performed.
We found this trial at
1
site
Click here to add this to my saved trials
